ISSN: 0960-894X

Journal Home

Journal Guideline

Bioorganic and Medicinal Chemistry Letters Q2 Unclaimed

Elsevier Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Bioorganic and Medicinal Chemistry Letters is a journal indexed in SJR in Molecular Biology and Biochemistry with an H index of 154. It has an SJR impact factor of 0.536 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0.536.

Bioorganic and Medicinal Chemistry Letters focuses its scope in these topics and keywords: inhibitors, derivatives, potent, receptor, synthesis, evaluation, activity, selective, protein, d, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Organic Chemistry (Q2) Pharmaceutical Science (Q2) Biochemistry (Q3) Clinical Biochemistry (Q3) Clinical Biochemistry (Q3) Drug Discovery (Q3) Molecular Biology (Q3) Molecular Medicine (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Bioorganic and Medicinal Chemistry Letters

0.536

SJR Impact factor

154

H Index

546

Total Docs (Last Year)

1948

Total Docs (3 years)

17914

Total Refs

5660

Total Cites (3 years)

1947

Citable Docs (3 years)

2.9

Cites/Doc (2 years)

32.81

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Biochimica et Biophysica Acta - Molecular Cell Research Q2
Molecular and Cellular Neurosciences Q2
Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids Q2
Human Gene Therapy Q2
Progress in Molecular Biology and Translational Science Q2

Compare this journals

Aims and Scope

Best articles by citations

Synthesis and PKC isozyme surrogate binding of indothiolactam-V, a new thioamide analogue of tumor promoting indolactam-V

Nonbenzamidine compounds as selective factor xa inhibitors

A QSAR study investigating the effect of l-alanine ester variation on the anti-HIV activity of some phosphoramidate derivatives of d4T

Peptidyl aldehyde derivatives as potent and selective inhibitors of cathepsin L

Enzymatic synthesis of (6R)- and (6S)-fluoroshikimic acids

Corrigendum to "First pharmacophoric hypothesis for 5-HT7 antagonism"

The binding of cocaine to cyclodextrins

Immunostimulatory activity of CpG containing phosphorothioate oligodeoxynucleotide is modulated by modification of a single deoxynucleoside

A Unique Ring-Expanded Acyclic Nucleoside Analogue that Inhibits Both Adenosine Deaminase (ADA) and Guanine Deaminase (GDA; Guanase): Synthesis and Enzyme Inhibition Studies of 4,6-Diamino-8H-1-hydroxyethoxymethyl-8-iminoimidazo[4,5-e][1,3]diazepine

The Synthesis and Selective IL-2 Inhibitory Activity of Bis Piperazine-Phenol Mannich Adducts

Discovery of selective metal-binding peptoids using 19F encoded combinatorial libraries

Cellular solid-phase binding assay and mass spectrometry for screening of a4beta7 integrin antagonists

SHOW MORE ARTICLES

Mechanistic studies on prolyl-4-hydroxylase: the vitamin c requiring uncoupled oxidation

Synthesis of a water-soluble prodrug of entacapone

Design and synthesis of a conformationally constrained analog of the bis(heteroaryl)piperazine (BHAP) HIV-1 reverse transcriptase inhibitor atevirdine

Design and synthesis of a novel class of histone deacetylase inhibitors

The Synthesis of 4-Arylsulfanyl-substituted Kainoid Analogues from trans-4-Hydroxy-l-proline

Computational binding studies of human pp60c-src SH2 domain with a series of nonpeptide, phosphophenyl-containing ligands

Stereo-random synthesis of highly functionalized proline analogues by azomethine cycloaddition

Design and synthesis of novel pyrrolobenzodiazepine (PBD) prodrugs for ADEPT and GDEPT

Win 70197: a novel liver-targeted magnetic resonance imaging contrast agent

Polyhydroxylated 3-(N-phenyl) carbamoyl-2-iminochromene derivatives as potent inhibitors of tyrosine kinase p60c-src

Unprecedented sugar-dependent in vivo antitumor activity of carbohydrate-pendant cis-diamminedichloroplatinum(II) complexes

Design and synthesis of potent thiol-based inhibitors of endothelin converting enzyme-1